Cargando…
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease
Nonalcoholic fatty liver disease (NAFLD), also named metabolic dysfunction-associated fatty liver disease (MAFLD), is a progressive disease spectrum encompassing simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. It is a clinically silent disease leading to multiple extr...
Autores principales: | Hassen, Gashaw, Singh, Abhishek, Belete, Gizeshwork, Jain, Nidhi, De la Hoz, Ivonne, Camacho-Leon, Genesis P, Dargie, Nitsuh K, Carrera, Keila G, Alemu, Tadesse, Jhaveri, Sharan, Solomon, Nebiyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242599/ https://www.ncbi.nlm.nih.gov/pubmed/35783879 http://dx.doi.org/10.7759/cureus.25495 |
Ejemplares similares
-
Deep Vein Thrombosis in Intravenous Drug Users: An Invisible Global Health Burden
por: Jain, Nidhi, et al.
Publicado: (2021) -
The Risk of Cardiovascular Disease Among Immigrants in Canada
por: Sebastian, Sneha A, et al.
Publicado: (2022) -
Clinical Implications of Herbal Supplements in Conventional Medical Practice: A US Perspective
por: Hassen, Gashaw, et al.
Publicado: (2022) -
Imatinib-Induced Pleuro-Pericardial Effusion and Atrial Fibrillation: An Unusual Side Effect Following the Treatment of a Rare Gastrointestinal Tumor
por: Patel, Neel N, et al.
Publicado: (2023) -
The Benefits and Barriers of Using Point-of-Care Ultrasound in Primary Healthcare in the United States
por: Carrera, Keila G, et al.
Publicado: (2022)